• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新解释良性行为干预豁免的理由。

An Argument for Reinterpreting the Benign Behavioral Intervention Exemption.

作者信息

Tully Ian

机构信息

Hecht-Levi Postdoctoral Fellow in the Berman Institute for Bioethics at Johns Hopkins University.

出版信息

Ethics Hum Res. 2021 Jul;43(4):20-26. doi: 10.1002/eahr.500096.

DOI:10.1002/eahr.500096
PMID:34196503
Abstract

Recent changes to the Common Rule have helped reduce regulatory burden on researchers conducting minimal risk research. However, in this paper, I propose a way of minimizing burden further within the existing confines of the current regulations. I focus my discussion on the newly created "benign behavioral interventions" category of exempt research, arguing that this exemption from the federal regulations governing research with human subjects should be more expansively interpreted by the Secretary's Advisory Committee on Human Research Protections (SACHRP) than is currently the case. Specifically, I argue against the restriction, advocated by SACHRP, that the exemption exclude "physical (bodily) tasks" unless they are "incidental to the behavioral intervention." This restriction, I argue, is problematically vague and does no significant moral work. Acceptance of my proposed reinterpretation of "benign behavioral interventions" would, I hope, result in a significant reduction in regulatory burden for minimal risk research.

摘要

最近对《共同规则》的修订有助于减轻从事最低风险研究的研究人员的监管负担。然而,在本文中,我提出了一种在现行法规的现有范围内进一步减轻负担的方法。我的讨论重点是新设立的豁免研究“良性行为干预”类别,认为负责保护人类研究对象的联邦法规给予的这一豁免,应由秘书人类研究保护咨询委员会(SACHRP)作出比目前更宽泛的解释。具体而言,我反对SACHRP所主张的限制,即该豁免应排除“身体(肉体)任务”,除非它们“附属于行为干预”。我认为,这一限制模糊得有问题,且没有起到重要的道德作用。我希望,接受我对“良性行为干预”的重新解释提议,将大幅减轻最低风险研究的监管负担。

相似文献

1
An Argument for Reinterpreting the Benign Behavioral Intervention Exemption.重新解释良性行为干预豁免的理由。
Ethics Hum Res. 2021 Jul;43(4):20-26. doi: 10.1002/eahr.500096.
2
Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations.在无直接受益前景的儿科研究中确定风险:就联邦法规的解释达成全国共识的时候了。
Am J Bioeth. 2007 Mar;7(3):5-10. doi: 10.1080/15265160601171572.
3
Implications of the Revised Common Rule for Qualitative Health Research: Opportunities, Concerns, and Recommendations.修订后的《共同规则》对定性健康研究的影响:机遇、担忧与建议。
Qual Health Res. 2022 Jan;32(2):385-393. doi: 10.1177/10497323211061101. Epub 2021 Dec 7.
4
Exemptions and Limited Institutional Review Board Review: A Practical Look at the 2018 Common Rule Requirements for Exempt Research.豁免与有限的机构审查委员会审查:审视2018年《通用规则》中豁免研究的要求
Ochsner J. 2020 Spring;20(1):87-94. doi: 10.31486/toj.19.0095.
5
Research ethics and the medical profession. Report of the Advisory Committee on Human Radiation Experiments.研究伦理与医学专业。人体辐射实验咨询委员会报告。
JAMA. 1996 Aug 7;276(5):403-9.
6
Are research subjects adequately protected? A review and discussion of studies conducted by the Advisory Committee on Human Radiation Experiments.研究对象是否得到了充分保护?对人类辐射实验咨询委员会开展的研究的回顾与讨论。
Kennedy Inst Ethics J. 1996 Sep;6(3):271-82. doi: 10.1353/ken.1996.0026.
7
Updating protections for human subjects involved in research. Project on Informed Consent, Human Research Ethics Group.更新参与研究的人类受试者的保护措施。知情同意项目,人类研究伦理小组。
JAMA. 1998 Dec 9;280(22):1951-8. doi: 10.1001/jama.280.22.1951.
8
SACHRP recommendations for review of children's research requiring DHHS secretary's approval.儿童研究保护审查小组(SACHRP)关于审查需卫生与公众服务部(DHHS)部长批准的儿童研究的建议。
IRB. 2005 May-Jun;27(3):8-10.
9
Site Variability in Regulatory Oversight for an International Study of Pediatric Sepsis.国际儿科脓毒症研究的监管监督中的站点变异性。
Pediatr Crit Care Med. 2018 Apr;19(4):e180-e188. doi: 10.1097/PCC.0000000000001455.
10
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.